ArticlePublisher preview availableLiterature Review

An expectancy-attribution model of the effects of placebos

Authors:
To read the full-text of this research, you can request a copy directly from the authors.

Abstract

Distinguishes between primary assessments, which measure the direct effects of expectancies associated with the placebo, and secondary assessments, which measure S's inferences about underlying dispositions that are not believed to be directly affected by the placebo (inductive effects). Placebos whose alleged impact will counteract the recipient's symptoms (counteractive expectancies) are distinguished from placebos whose alleged effects will parallel the recipient's symptoms (parallel expectancies). Research findings are reviewed and classified into 1 of 4 cells produced by a combination of these 2 factors. Standard placebo effects (changes in the recipient's condition in accordance with the placebo's alleged impact) were found to be most common on primary assessments of counteractive expectancies placebos; reverse inductive effects (altered inferences about an underlying disposition, in the direction opposite to the placebo's alleged impact) were most common on secondary assessments of parallel expectancies placebos. Psychological processes that underlie these effects and implications for clinical practice are considered. (94 ref)
Psychological
Review
1981,
Vol.
88, No. 5,
408-437
Copyright
1981
by the
American Psychological Association, Inc.
0033-295X/81
/8805-0408S00.75
An
Expectancy-Attribution Model
of the
Effects
of
Placebos
Michael Ross
University
of
Waterloo
Waterloo, Ontario, Canada
James
M.
Olson
University
of
Western Ontario
London,
Ontario, Canada
A
model
is
presented
to
resolve
the
inconsistencies
in the
literature
on the
effects
of
placebos. Primary assessments, which measure
the
direct
effects
of the ex-
pectancies associated with
the
placebo,
are
distinguished
from
secondary
as-
sessments, which measure
the
subject's inferences about
underlying
dispositions
that
are not
believed
to be
directly affected
by the
placebo
(inductive
effects).
Also,
placebos whose alleged impact
will
counteract
the
recipient's symptoms
(counteractive expectancies)
are
distinguished
from
placebos whose alleged
ef-
fects
will
parallel
the
recipient's symptoms (parallel
expectancies).
The
relevant
findings are
reviewed
and
classified
into
one of the
four
cells produced
by a
combination
of
these
two
factors. Standard placebo effects (changes
in the re-
cipient's condition
in
accordance
with
the
placebo's alleged impact) were most
common
on
primary assessments
of
counteractive expectancies placebos; reverse
inductive
effects (altered inferences about
an
underlying
disposition,
in the di-
rection
opposite
to the
placebo's alleged impact) were most common
on
secondary
assessments
of
parallel expectancies placebos. Psychological processes that might
underlie
these effects,
and
implications
of the findings for
research
on
placebo
effects
and for
clinical practice
are
considered.
A
placebo
is a
substance
or
procedure
that
is
administered with suggestions
that
it
will
modify
a
symptom
or
sensation
but
which,
unknown
to its
recipient,
has no
specific
pharmacological impact
on the
reaction
in
question.
A
standard placebo effect occurs
when
the
administration
of the
placebo
al-
ters
the
recipient's
state
in
accordance
with
its
presumed impact.
Physicians have employed
placebos
for
centuries
to
alleviate human suffering.
In-
deed,
until
the
beginning
of
this century,
most medicines
had no
specific pharmaco-
logical
properties
that
could assist healing
(Honigfeld,
1964au
Houston,
1938;
Shapiro,
This article
was
partially prepared
while
the first au-
thor
was a
Visiting Scholar
at the
Department
of
Psy-
chology,
Stanford University.
The
writing
of the
article
was
supported
by a
Canada Council Leave Fellowship
and
a
Social Sciences
and
Humanities Research Council
research grant
to the first
author.
We are
grateful
to
Richard Bootzin, Garth Fletcher,
Tory Higgins, John Holmes, Nick
Kuiper,
Kevin
McCaul,
Donald
Meichenbaum,
Clive
Seligman, Neil
Vidmar,
Mark Zanna,
and an
anonymous reviewer
for
their
comments
on an
earlier version
of the
manuscript.
Requests
for
reprints
can be
sent
to
Michael Ross,
Department
of
Psychology, University
of
Waterloo,
Waterloo, Ontario, Canada
N2L
3G1.
1971;
Shapiro
&
Morris, 1978).
The as-
sortment
of
therapies used
by
healers
was
astonishingly diverse, including such deli-
cacies
as
"lizard's
blood, crocodile dung,
the
teeth
of
swine,
the
hoof
of an
ass,
putrid
meat,
and fly
specks"
(Honigfeld,
1964a,
p.
145).
As an
example
of the
medical treatment
lavished
on our
forefathers, consider
the
fol-
lowing
attempts
to
cure
George
Washington
of
what
was
probably
a
throat infection com-
pounded
by
pneumonia:
Because
he
could
afford
the
best cure available,
he was
given
a
mixture
of
molasses,
vinegar,
and
butter,
and
then made
to
vomit
and
have
diarrhea.
But
he
lapsed.
In
desperation,
his
physicians
ap-
plied
irritating poultices
to
blister
his
feet
and his
throat,
while
draining several pints
of
blood. Then
he
died. (Power, 1978,
p. 24)
Remedies
of
true value were introduced only
rarely,
as
when fresh fruits were
used
to
cure
scurvy.
Astute
observers questioned
the
efficacy
of
medical
treatments; note,
for
example,
the
disdain with which
the
French playwright
Moliere
treated physicians. Nevertheless,
healers
attained high standing
in all
cultures.
408
... In the past few years, several person-perception theories have viewed judgments about personality characteristics as end products of a sequence of processing stages (see Gilbert, 1989;McArthur & Baron, 1983;Ross & Olson, 1981;Trope, 1986). These theories share the assumption that largely automatic perceptual categorizations of behavioral data precede more deliberate inferences regarding personality dispositions. ...
Article
Full-text available
According to Trope's (1986) 2-stage model, the use of situational information (“A was teased”) to identify behavior (“A reacted aggressively”) may result in subsequent dispositional inferences (“A is an aggressive person”) that seem insensitive to situational information. Two determinants of the situational biasing effect on behavior identification were varied, namely, behavior ambiguity and order of situational and behavioral information. It was found that when behavior was ambiguous and preceded by situational information, the latter affected behavior identification but not dispositional inference; in contrast, when behavior was unambiguous or when it was followed by situational information, the latter affected dispositional inference but not behavior identification. Thus, the same conditions that allowed situational information to bias behavior identification also nullified the effect of situational information on dispositional inference.
... The expectation that such physiological sensations will exist can elicit them, at least to a faint degree, and further selective attention can strengthen them. Research on expectancy effects, especially on placebo effects, confirms the ability of expectations to generate actual physiological changes (Marlatt & Rohsenow, 1982;Ross & Olson, 1981). ...
Article
Full-text available
It is useful to reconceptualize social support as coping assistance. If the same coping strategies used by individuals in response to stress are those that are applied to distressed persons as assistance, models of coping and support can be integrated. To illustrate the utility of such an integration, coping strategies and support strategies are derived from a more general theory of stress-buffering processes in this article. A variety of supportive strategies not previously identified by researchers are derived. Further, predictions regarding efficacious and nonefficacious types of support are made, and empathic understanding (based on sociocultural and situational similarities between a distressed person and a helper) is identified as a crucial condition for coping assistance to be sought, accepted, and found effective.
... Hogy mégis legyen fogalmunk, álljon itt a többféle definícióból az egyik legjobb: "Placebónak nevezünk minden olyan anyagot vagy eljárást, ami az érintett tudomása szerint változtatni képes bizonyos tüneteket vagy külső-belső testi észleleteket, ám valójában nem bír az e változásokhoz szükséges farmakológiai vagy specifikus hatással" (Ross-Olson 1981). Orvosi esetben tehát olyan szerekről vagy kezelésekről van szó, amelyek az adott állapotra nincsenek specifikus hatással, de erről a betegnek nincs tudomása. ...
Article
Full-text available
Összefoglaló. A belső szervek működési zavarai gyakran származnak viselkedési, lelki vagy pszichoszociális okokból, amelyeknek nem mindig vagyunk tudatában. Minthogy ebben a folyamatban egy bonyolult neuronális hálózat játssza a fő szerepet, ezeknek a zavaroknak a diagnózisa és terápiája számos tényező manipulálását igényli. A funkcionális gyomor-bélhuzam rendellenességek (FGID), például az irritábilisbél-szindróma (IBS), jellemző példái ennek: olyan működési zavarokról van szó, amelyek mögött jól detektálható szervi vagy biokémiai elváltozásokat nem találnak. Ilyenkor szükségesnek tűnik a komplex megközelítés, amely többféle szakember együttműködését kívánja meg. Szerepe lehet a pszichés vagy életmód terápiának, a gyógyszeres és fizikai kezelésnek is, és – ahogy ebben a cikkben megmutatjuk – a placebo-terápiának is. Summary. Functional disorders of the internal organs frequently are results of behavioral, mental or psycho-social dysfunctions, although we are usually not conscious about it. A typical example isirritable bowel syndrome (IBS), a characteristic functional gastro-intestinal disorder (FGID), which is regularly accompanied by abdominal pain and irregular intestinal motility and defecation. It has been shown that this disorder cannot be due to a single factor, nor is it a result of a local cause. Recently researchers have proven that malfunction of a complicated neuronal network, including several brain sites, may be responsible for IBS. It is believed now that IBS is the consequence of several nocebo-effects. IBS is a typical source of visceral pain or discomfort, a source that is frequently difficult to identify. Main factors are stimuli originating from the gastro-intestinal tract, passing through the spinal cord and reaching several brain structures, including cortical and sub-cortical sites. It has been shown that some structures become thicker while others thinner as a result of lasting visceral pain, resulting in altered top-down effects on the visceral organs. Several hormones accompany these processes resulting in a complicated network activity. Recent research has revealed that IBS requires a complex approach, optimally provided by a therapeutic team of physicians, psychologist/psychiatrist, associates, and even the patient himself/herself. They may apply or suggest medicines, physiotherapy, lifestyle modifications, alimentary changes etc. An important feature is that the nocebo-effect plays an important role in the generation of IBS, thus one may think the opposite phenomenon, placebo-effect could be used in the therapeutic process. And really, placebo-analgesia is a method frequently used in the therapy of IBS. Placebo-analgesia affects brain processes, including pain processing, release of hormones, including endogenous opioids, the primary pain-decreasing factors. A top-down pain-modification system exists which can be affected and activated by the placebo-analgesia thus counteracting the nocebo-effects and improving the condition of the individual. The placebo phenomenon is interesting in itself, too. By now, the major question is not the existence of the placebo-effect but the mechanisms behind it. Recently, as brain-mapping techniques have gained their role in research, a lot of new information proves that the placebo-effect (as well as the nocebo-effect) is a complex phenomenon that involves several different brain sites, including the brain cortex and the limbic system, respectively.P The placebo-effect is widely used in clinical practice, first of all as a reference treatment when new drugs or medicines are tested for their effectivity. There are numerous ethical problems in this area, recently, for example, when testing Covid-19 vaccines. The main problem is whether it is legal to keep a non-treated population, whether the placebo-group should be treated immediately after the trial ends, whether the members of the placebo-group should get adequate information.
... Thus, many drugs consumed by students to enhance their exam performance may not represent more than placebos (see e.g. Ross & Olson, 1981) which at best leads to an overestimation of their effects (see Bray et al., 2004). ...
Article
Full-text available
The present study carried out in Germany is concerned with social work students' consumption of either non-prescribed medicine (e.g. amphetamine) or illegal drugs (such as cocaine) to improve their cognitive performance (neuroenhancement) during examinations. In the main study (n = 257), 16% reported to have consumed such substances, including more men than women and more older than younger students. The use of drugs was neither influenced by study-related variables (e.g. performance pressure) nor parent-related factors (e.g. high-performance expectations). However, as expected by the Theory of Planned Behavior, there were impacts of (1) students' belief in the supposed effectiveness of neuroenhan-cers, (2) their affiliation to a 'doping' student minority group, and (3) the possibility and situational ease of procurement of such substances. The conclusions were supported by a replication study (n = 444). Finally, implications of these results for social work education are discussed. ARTICLE HISTORY
Article
Placebo and nocebo effects have been well documented for nearly two centuries. However, research has only relatively recently begun to explicate the neurobiological underpinnings of these phenomena. Similarly, research on the broader social implications of placebo/nocebo effects, especially within healthcare delivery settings, is in a nascent stage. Biological and psychosocial outcomes of placebo/nocebo effects are of equal relevance. A common pathway for such outcomes is the endogenous opioid system. This chapter describes the history of placebo/nocebo in medicine; delineates the current state of the literature related to placebo/nocebo in relation to pain modulation; summarizes research findings related to human performance in sports and exercise; discusses the implications of placebo/nocebo effects among diverse patient populations; and describes placebo/nocebo influences in research related to psychopharmacology, including the relevance of endogenous opioids to new lines of research on antidepressant pharmacotherapies.
Chapter
Treatment in medicine is a medical intervention that can be performative, intentional, emotional, hortatory, or persuasive, which assumes patient compliance. A treatment may be efficient or effective. Abortion, or euthanasia, even without request may sometimes be therapeutic options. Most treatments have undesirable side-effects. Placebos and nocebos are part of the meaning of therapeutic procedures.
Article
Objective The purpose of the current field study was to investigate the relationships between personality traits and placebo responsiveness, and the effects of alcohol and placebo alcohol on the changes of the subjective state and behavior among participants (N = 64, gender ratio 50% men: 50% women, mean age = 26.64). We suggest that expectations associated with alcohol consumption itself can lead to subjective and objective inebriation, and some individuals respond better to placebo than others, so placebo reactivity is associated with certain personality traits. Method In the present field study, the effect of placebo alcohol is measured in a typical alcohol consumption social setting, and the study seeks to explore relationships among certain personality traits (sociability and extraversion, spirituality and religiosity and dispositional optimism) and placebo responsiveness, furthermore the effects of alcohol and placebo alcohol on subjective and objective intoxication. Results In this study, the expectation induced classical placebo effect in the field was successfully demonstrated, while no support for a relationship between personal traits and placebo responsiveness was found. Conclusion Based on the results, a desirable goal is to reframe the inebriated state that is often considered “desirable” by young people by raising awareness of the placebo effect.
Chapter
The chapter discusses three interventions that are often accompanied by pleasant body sensations: placebo treatment, complementary and alternative medicine, and mind–body techniques, such as yoga, tai chi chuan, and mediation. Following these interventions, subjective well-being usually improves due to the increase of positive affect and happiness and/or decrease of negative affect. Although this effect is positive and desirable, it is not without pitfalls. As we cannot directly sense the majority of (patho)physiological changes taking place in the body, higher level of well-being biases our overall appraisal of our actual health condition; in other words, feeling better often means feeling cured. This might lead to worse adherence to effective conventional treatments and even delays in the treatment, which can lead to fatal consequences in degenerative diseases with rapid progression. Overall, the perceived condition of the body should not be used as an indicator of actual health state.
Thesis
This thesis contains a review of the literature concerning chronic idiopathic facial pain (CIFP) its presentation, management and psychological aspects. A two part study is then described: i. Treatment uptake The aim of the study was to measure psychological and objective parameters in patients attending for treatment of CIFP and investigate their association with acceptance of treatment. An assessment of clinical and psychological factors was made in 848 patients; of those with CIFP (713), 46% of patients declined treatment, 28% opted for routine treatment (10% due to trial exclusion criteria) and 26% accepted treatment within the study. The only predictors of treatment uptake were pain severity (p<0.00l), presence of constant pain (p<0.05) and age and marital status (p<0.01). ii. Treatment outcome: A comparison of cognitive behavioural therapy alone and in conjunction with an antidepressant drug. This randomised placebo-controlled study aimed to assess the effectiveness of treatment of chronic idiopathic facial pain with either a) fluoxetine; b) placebo; c) fluoxetine and cognitive behavioural therapy (CBT) and d) placebo and CBT in a cohort of 181 patients, over a period of three months. Pain and psychological measures were made during the treatment phase and an additional nine month follow up. Three months treatment with fluoxetine alone or in combination with CBT improved measures of pain severity (p<0.005), distress (p<0.05) and interference (p<0.05). Control was improved in those patients receiving CBT (p<0.05). During the follow up period when trial drug therapy had ceased, these changes were not maintained. However the need for further medical therapy was less in the CBT group. The final pain score was predicted only by the initial pain severity scores (p<0.001) and the time in follow up (p<0.05).
Article
Full-text available
Attempted to replicate and delimit the reverse placebo effect found by M. D. Storms and R. E. Nisbett in 48 paid insomniacs (age range, 17-58 yrs). It was predicted that the reverse placebo effect would obtain when the pills’ effects were described as affecting arousal (as in Storms and Nisbett’s study) but that a direct suggestion effect would result when the pills were described as directly affecting sleep onset latency. Findings indicate that direct suggestion effects obtained regardless of the focus of the instructions. The present investigation, together with the results of R. Kellogg and R. S. Baron (1975) call into question the reliability and clinical significance of the reverse placebo effect in the treatment of insomnia.
Article
Full-text available
Critically reviews the literature assessing the importance of Ss' expectation of therapeutic gain in facilitating fear reduction. Reviewed studies fall into 2 major categories: those that compare the relative efficacy of systematic desensitization and placebos and those that attempt to manipulate Ss' expectation of therapeutic gain within a particular technique (e.g., systematic desensitization). The methodological problems with this research include the failure of investigators to evaluate the experiential impact of expectancy-inducing instructions, the use of unconvincing placebo manipulations, and the predominant employment of mildly fearful, poorly motivated Ss. In spite of these problems, it is tentatively concluded that expectancy manipulations are important change mediators. Several mechanisms may explain how expectancy mediates change, including increased compliance with real treatment procedures; increased tendency to test reality after having undergone an "effective" therapy, with subsequent fear extinction and self-reinforcement for behavioral improvement; modification of demand characteristics after treatment; and modification of cognitive events controlling fear responding. (71 ref)
Article
Full-text available
An experimental misattribution paradigm proved to be a significant intervention treatment of altering social participation among 14 dispositionally shy undergraduate women. When specific arousal symptoms previously associated with their social anxiety were misattributed to a nonpsychological source (high-frequency noise), Ss behaved as if they were not shy. Their verbal fluency and interactional assertiveness resembled that of 16 not-shy Ss given the same treatment. Moreover, their scores on these measures were significantly elevated from the low levels recorded by 15 shy controls who had been led to expect shyness-irrelevant "side effects" from their exposure to noise. A male partner (a confederate) accurately perceived whether or not Ss in the 2 control groups were shy, but he misjudged as "not shy" the shy Ss in the misattribution group. The greater enjoyment of the interaction by those in this latter group, despite high-frequency noise bombardment, was also reflected in their stronger preference for further affiliation than that shown by either comparison group. The continuously monitored heart rate data provide grounds for speculation as to the relationship of physiological arousal and behavior. However, a paradoxical placebo finding emerged when it appeared that not-shy Ss in this same misattribution condition experienced a higher level of arousal, and this anxiety-like arousal was associated with preferences for nonaffiliation. (23 ref) (PsycINFO Database Record (c) 2006 APA, all rights reserved).
Article
Evidence is reviewed which suggests that there may be little or no direct introspective access to higher order cognitive processes. Subjects are sometimes (a) unaware of the existence of a stimulus that importantly influenced a response, (b) unaware of the existence of the response, and (c) unaware that the stimulus has affected the response. It is proposed that when people attempt to report on their cognitive processes, that is, on the processes mediating the effects of a stimulus on a response, they do not do so on the basis of any true introspection. Instead, their reports are based on a priori, implicit causal theories, or judgments about the extent to which a particular stimulus is a plausible cause of a given response. This suggests that though people may not be able to observe directly their cognitive processes, they will sometimes be able to report accurately about them. Accurate reports will occur when influential stimuli are salient and are plausible causes of the responses they produce, and will not occur when stimuli are not salient or are not plausible causes.
Article
• Isoniazid given thrice daily in 100-mg. capsules was compared with a placebo as to its effects on patients with multiple sclerosis. Special efforts were made to verify the diagnosis, avoid unnecessary risks to the patient, extend the period of observation sufficiently to provide a real test, include enough patients in whom the disease had been recently active, and eliminate bias through randomization and double-blind procedures. The 186 patients finally selected were enrolled in 11 hospitals; 88 received isoniazid and 98 received the placebo. In evaluating the results each patient was rated as to the severity of his symptoms according to the modified Kurtzke scale before and after the period of medication; the patient was also rated as to a variety of specific neurological changes, self-care score, and ambulation score. By all criteria, including laboratory findings and over-all clinical impressions, the differences between the isoniazid and placebo groups were insignificant. No beneficial effects that could be ascribed to isoniazid in multiple sclerosis were observed in nine months or more of follow-up.